Clinical Trial Update: Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a multimodal approach with paclitaxel, cisplatin, gefitinib, radiation, surgery, and gefitinib for locally advanced esophageal or gastr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gefitinib (Gefitinib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Esophageal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-12-06